← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2012Last known activity
Apr 30, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT03721497Lead sponsorPhase 4Apr 30, 2019
- NCT03721497Reponsible party - principal investigatorPhase 4Apr 30, 2019
- NCT02563353CollaboratorN/ANov 1, 2015
- NCT02229292Lead sponsorPhase 4Aug 19, 2014
- NCT02229292Reponsible party - principal investigatorPhase 4Aug 19, 2014
- NCT02229292Overall official - principal investigatorPhase 4Aug 19, 2014
- NCT02013479CollaboratorN/AJun 1, 2014
- NCT02013479Overall official - principal investigatorN/AJun 1, 2014
- NCT01879917CollaboratorPhase 2/Phase 3Oct 1, 2013
- NCT01611896Study chairN/AOct 1, 2012
- NCT01611896CollaboratorN/AOct 1, 2012
Details
- Founded
- Esbjerg, DK
- Last known activity
- Apr 30, 2019